Close up of medical drip or IV drip chamber in patient room.

Results published of remdesivir, COVID-19 trial

May 28, 2020

According to the study, the drug improved recovery time and decreased the number of deaths.

An image of the virus that causes COVID-19 emerging from a cell

NEJM publishes results of remdesivir, COVID-19 trial conducted by UT Health San Antonio, University Hospital

May 28, 2020

SAN ANTONIO (May 29, 2020) — San Antonio patients with severe COVID-19 lung disease contributed to an international study published May 22 in the New England Journal of Medicine. The study outlined preliminary results of the recent Adaptive Covid-19 Treatment Trial, conducted partly in San Antonio, testing a new anti-viral drug called remdesivir. Thomas Patterson, […]

UT Teen Health reaches out in times of need

May 26, 2020

UT Teen Health, an adolescent health and wellness program of UT Health San Antonio, has been reaching out to the community during the COVID-19 pandemic.

Study: Childhood trauma, lack of support influence opioid use, overdose among new mothers

May 26, 2020

SAN ANTONIO (May 26, 2020) — New mothers who have returned to using opioids or have died of an overdose often have a troubled past going back to their childhood. The death of a parent, abuse by a trusted individual, the routine use of drugs in the home or problems with relationships later as an […]

Have you missed your cancer screenings?

May 22, 2020

Mays Cancer Center experts to discuss why getting screenings now is important during May 29 webinar  SAN ANTONIO (May 22, 2020) — Studies have shown that individuals with cancer who get COVID-19 are more likely to have poor outcomes. And with everyone staying home during the pandemic, many people have missed their regular cancer screenings. […]

Close up of medical drip or IV drip chamber in patient room.

Second phase of clinical trial for promising COVID-19 drug begins

May 15, 2020

Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.